Breaking News Instant updates and real-time market news.

2021-01-22 11:17:07 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 11:17 01/22/21 01/22 11:17 01/22/21 11:17	NASDAQ market internals summary Volume is above average for this time of day. Breadth is mixed with issues bearish while volume and new highs to new lows are bullish. Advancing Issues: 1394 / Declining Issues: 2268 -- for a ratio of 0.6 to 1. Advancing Volume: 1,223,161,000 / Declining Volume: 1,008,050,000 -- for a ratio of 1.2 to 1. New 52-Week Highs: 234 / New 52-Week Lows: 13.

2021-01-22 11:17:07

$NSD

NASDAQ Market Internals

$0.00 / + (+0.00%)

11:17

01/22/21

01/22

11:17

01/22/21

11:17

NASDAQ market internals summary

Volume is above average for this time of day. Breadth is mixed with issues bearish while volume and new highs to new lows are bullish. Advancing Issues: 1394 / Declining Issues: 2268 -- for a ratio of 0.6 to 1. Advancing Volume: 1,223,161,000 / Declining Volume: 1,008,050,000 -- for a ratio of 1.2 to 1. New 52-Week Highs: 234 / New 52-Week Lows: 13.

TODAY'S FREE FLY STORIES

Hot Stocks	Exicure receives orphan drug designation for cavrotolimod from FDA » 07:07 03/03/21 03/03 07:07 03/03/21 07:07 XCUR Exicure $2.29 / +0.08 (+3.63%) Exicure announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly XCUR Exicure $2.29 / +0.08 (+3.63%) 03/02/21 Exicure's cavrotolimod granted FDA orphan status for merkel cell carcinoma 01/11/21 Exicure granted two FDA fast track designations for cavrotolimod 12/21/20 Exicure announces issuance of two new U.S. patents, and new patent allowance 12/21/20 Exicure announces issuance of two new U.S. patents, and new patent allowance XCUR Exicure $2.29 / +0.08 (+3.63%) 12/18/20 BMO Capital Exicure initiated with an Outperform at BMO Capital XCUR Exicure $2.29 / +0.08 (+3.63%) 11/12/20 Exicure reports Q3 EPS (3c), consensus (9c) XCUR Exicure $2.29 / +0.08 (+3.63%) 12/18/20 Fly Intel: Wall Street's top stories at midday 12/18/20 Fly Intel: Pre-market Movers
Earnings	Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c » 07:07 03/03/21 03/03 07:07 03/03/21 07:07 WEN Wendy's $21.30 / +0.01 (+0.05%) Sees FY21 Global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 07:05 Today Wendy's reports Q4 global same-restaurant sales growth 4.7% 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Hot Stocks	Optinose expects topline results from OPN-019 study in 2Q21 » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 OPTN Optinose $3.92 / -0.085 (-2.12%) In June 2020, the Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 07:05 Today Optinose expects topline results from one XHANCE trial by end of 2021 07:04 Today Optinose sees FY21 XHANCE revenues at least $80M 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:05 Today Optinose expects Q1 XHANCE revenues to decrease vs. Q4 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN
Downgrade	Pollard Banknote downgraded to Hold from Buy at Canaccord » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 PBKOF Pollard Banknote $0.00 / + (+0.00%) Canaccord analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PBKOF Pollard Banknote $0.00 / + (+0.00%) 02/09/21 Raymond James Pollard Banknote initiated with an Outperform at Raymond James 01/04/21 Canaccord Pollard Banknote price target raised to C$40 from C$25 at Canaccord 11/10/20 Canaccord Pollard Banknote price target raised to C$25 from C$21 at Canaccord 05/07/20 Canaccord Pollard Banknote price target raised to C$19 from C$18 at Canaccord
Hot Stocks	Emerson Electric announces first chief sustainability officer. Mike Train » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 EMR Emerson Electric $87.61 / -0.82 (-0.93%) To enhance its focused… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/25/21 Emerson Electric invests in Fluxa 02/17/21 Emerson Electric names Ram Krishnan COO 02/01/21 Emerson Electric CEO Farr to retire Lal Karsanbhai to succeed 12/17/20 Emerson Electric reports November trailing three-month orders down 4% EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/04/21 JPMorgan Emerson Electric price target raised to $95 from $85 at JPMorgan 02/03/21 Citi Emerson Electric price target raised to $98 from $94 at Citi 01/19/21 Goldman Sachs Emerson Electric upgraded to Buy from Neutral at Goldman Sachs 01/15/21 UBS Emerson Electric upgraded to Buy from Neutral at UBS EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/02/21 Emerson Electric sees FY21 EPS $3.70 +/- 10c consensus $3.51 02/02/21 Emerson Electric reports Q1 EPS 83c, consensus 69c 11/03/20 Emerson Electric sees FY21 adjusted EPS $3.45 +/- 5c, consensus $3.42 11/03/20 Emerson Electric reports Q4 adjusted EPS $1.10, consensus 94c EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/04/21 Emerson Electric considering sale of Appleton unit, Bloomberg says

Upgrade	Medexus Pharmaceuticals upgraded to Buy from Hold at Canaccord » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 MEDXF Medexus Pharmaceuticals $0.00 / + (+0.00%) Canaccord analyst Tania… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research MEDXF Medexus Pharmaceuticals $0.00 / + (+0.00%) 02/24/21 Stifel Medexus Pharmaceuticals price target raised to C$17.50 from C$7.25 at Stifel
Hot Stocks	Optinose expects topline results from one XHANCE trial by end of 2021 » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 OPTN Optinose $3.92 / -0.085 (-2.12%) The Company expects… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 07:04 Today Optinose sees FY21 XHANCE revenues at least $80M 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:05 Today Optinose expects Q1 XHANCE revenues to decrease vs. Q4 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN
Earnings	Patterson Companies reports Q3 adjusted EPS 58c, consensus 51c » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 PDCO Patterson Companies $32.39 / +0.03 (+0.09%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 12/30/20 Patterson Companies reports Heartland selects competitor as distribution partner PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 12/30/20 Piper Sandler Patterson contract loss unexpected but manageable, says Piper Sandler 12/03/20 Barclays Patterson Companies price target raised to $25 from $21 at Barclays 12/02/20 Piper Sandler Patterson Companies price target raised to $33 from $25 at Piper Sandler 11/10/20 Guggenheim Patterson Companies downgraded to Neutral from Buy at Guggenheim PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 12/02/20 Patterson Companies reports Q2 EPS 63c, consensus 38c 09/03/20 Patterson Companies reports Q1 adj. EPS 33c, consensus 23c PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 09/03/20 Fly Intel: Pre-market Movers 10:00 Today Patterson Companies - PDCO PDCO Patterson Companies $32.39 / +0.03 (+0.09%) 12/02/20 Early notable gainers among liquid option names on December 2nd 09/24/20 Early notable gainers among liquid option names on September 24th
Hot Stocks	Wendy's reports Q4 global same-restaurant sales growth 4.7% » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 WEN Wendy's $21.30 / +0.01 (+0.05%) Reports Q4 U.S.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 11/04/20 Wendy's raises quarterly dividend 40% to 7c per share WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Earnings	Optinose expects Q1 XHANCE revenues to decrease vs. Q4 » 07:05 03/03/21 03/03 07:05 03/03/21 07:05 OPTN Optinose $3.92 / -0.085 (-2.12%) Revenue consensus… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 07:04 Today Optinose sees FY21 XHANCE revenues at least $80M 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN

Earnings	Calumet Specialty Products reports Q4 EPS (89c), consensus (79c) » 07:04 03/03/21 03/03 07:04 03/03/21 07:04 CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) 02/01/21 Calumet Specialty Products to enter into a sale-leaseback transaction 10/05/20 Commercial Vehicle Group names Christopher Bohnert as CFO CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) 12/15/20 Wells Fargo Calumet Specialty Products downgraded to Equal Weight at Wells Fargo 12/15/20 Wells Fargo Calumet Specialty downgraded to Equal Weight from Overweight at Wells Fargo CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) 11/06/20 Calumet Specialty Products reports Q3 adjusted EPS (49c), consensus (38c) CLMT Calumet Specialty Products $4.32 / +0.05 (+1.17%) 10/01/20 Calumet weighing sale of finished lubricants division, Bloomberg says 09:00 Today Calumet Specialty Products - CLMT
Hot Stocks	Optinose sees FY21 XHANCE revenues at least $80M » 07:04 03/03/21 03/03 07:04 03/03/21 07:04 OPTN Optinose $3.92 / -0.085 (-2.12%) Revenue consensus… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN
Upgrade	Richemont upgraded to Overweight from Neutral at JPMorgan » 07:03 03/03/21 03/03 07:03 03/03/21 07:03 CFRUY Richemont $0.00 / + (+0.00%) JPMorgan analyst Chiara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CFRUY Richemont $0.00 / + (+0.00%) 11/05/20 Farfetch, Alibaba, Richemont form luxury digitization partnership CFRUY Richemont $0.00 / + (+0.00%) 02/17/21 Deutsche Bank Richemont price target raised to CHF 104 from CHF 100 at Deutsche Bank 02/16/21 Morgan Stanley Richemont price target raised to CHF 100 from CHF 87 at Morgan Stanley 02/09/21 Citi Richemont upgraded to Buy from Neutral at Citi 02/02/21 RBC Capital Richemont price target raised to CHF 100 from CHF 95 at RBC Capital
Hot Stocks	Wendy's reports Q4 U.S. systemwide sales growth of 14.2% » 07:03 03/03/21 03/03 07:03 03/03/21 07:03 WEN Wendy's $21.30 / +0.01 (+0.05%) Reports Q4: International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 11/04/20 Wendy's raises quarterly dividend 40% to 7c per share 10/19/20 Wendy's names Kevin Vasconi as Chief Information Officer WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Downgrade	Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold » 07:03 03/03/21 03/03 07:03 03/03/21 07:03 LIVN LivaNova $76.17 / -0.59 (-0.77%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LIVN LivaNova $76.17 / -0.59 (-0.77%) 12/03/20 LivaNova to divest heart valve business to Gyrus for $73M, sees dilution 10/29/20 LivaNova CFO Thad Huston stepping down, Alex Shvartsburg appointed Interim CFO 10/12/20 LivaNova confirms discussions with PrimeStone Capital over past several months 10/12/20 PrimeStone Capital sends letter to LivaNova, says shares reach $100 LIVN LivaNova $76.17 / -0.59 (-0.77%) 05:24 Today Berenberg LivaNova downgraded to Hold from Buy at Berenberg 02/24/21 Piper Sandler LivaNova price target raised to $81 from $73 at Piper Sandler 02/03/21 Piper Sandler Piper says pending epilepsy drug deal 'bears monitoring" by LivaNova holders 01/12/21 Piper Sandler LivaNova price target raised to $73 from $70 at Piper Sandler LIVN LivaNova $76.17 / -0.59 (-0.77%) 02/24/21 LivaNova sees 2021 adjusted EPS $1.40-$1.90, consensus $1.98 02/24/21 LivaNova reports Q4 adjusted EPS 71c, consensus 66c 10/29/20 LivaNova still sees FY20 adjusted EPS $1.15-$1.35, consensus $1.18 10/29/20 LivaNova reports Q3 adjusted EPS 38c, consensus 20c

Earnings	Optinose reports Q4 EPS (46c), consensus (46c) » 07:02 03/03/21 03/03 07:02 03/03/21 07:02 OPTN Optinose $3.92 / -0.085 (-2.12%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN
Upgrade	Hermes upgraded to Neutral from Underweight at JPMorgan » 07:02 03/03/21 03/03 07:02 03/03/21 07:02 HESAY Hermes $0.00 / + (+0.00%) JPMorgan analyst Chiara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HESAY Hermes $0.00 / + (+0.00%) 02/23/21 UBS Hermes price target raised to EUR 1,062 from EUR 924 at UBS 02/22/21 Morgan Stanley Hermes price target raised to EUR 945 from EUR 860 at Morgan Stanley 02/22/21 JPMorgan Hermes price target raised to EUR 755 from EUR 635 at JPMorgan 02/22/21 Deutsche Bank Hermes price target raised to EUR 700 from EUR 600 at Deutsche Bank
General news	MBA Mortgage Applications Composite Index data reported » 07:02 03/03/21 03/03 07:02 03/03/21 07:02 Week of 2/26 MBA Mortgage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	CECO Environmental reports Q4 non-GAAP EPS 16c, consensus 10c » 07:02 03/03/21 03/03 07:02 03/03/21 07:02 CECE CECO Environmental $8.21 / -0.12 (-1.44%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Earnings Events CECE CECO Environmental $8.21 / -0.12 (-1.44%) 11/04/20 CECO Environmental reports Q3 non-GAAP EPS 11c, consensus 11c 03/15/21 33rd Annual Roth Virtual Conference 08:30 Today CECO Environmental - CECE
Syndicate	Stratasys 6.897M share Spot Secondary priced at $29.00 » 07:01 03/03/21 03/03 07:01 03/03/21 07:01 SSYS Stratasys $32.27 / -4.12 (-11.32%) The deal range was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/01/21 Stratasys expects Q1 revenue to track similarly to 1Q20 02/18/21 Stratasys acquires U.K.-based RP Support Ltd., terms not stated 02/18/21 Stratasys acquires RPS, provider of best-in-class' stereolithography 3D printers 12/09/20 Stratasys to acquire Origin for total consideration of up to $100M SSYS Stratasys $32.27 / -4.12 (-11.32%) 01/19/21 Stifel Stratasys initiated with a Buy at Stifel 01/15/21 JPMorgan Stratasys downgraded to Underweight from Neutral at JPMorgan 10/09/20 Berenberg Stratasys initiated with a Buy at Berenberg 09/24/20 Fly Intel: Top five analyst downgrades SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/01/21 Stratasys reports Q4 EPS 13c, consensus 0c 11/12/20 Stratasys reports Q3 non-GAAP EPS (5c), consensus (7c) 03 Mar SSYS Stratasys $32.27 / -4.12 (-11.32%) 03/02/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: Pre-market Movers SSYS Stratasys $32.27 / -4.12 (-11.32%) 02/25/21 Stratasys call volume above normal and directionally bullish 01/07/21 Stratasys call volume above normal and directionally bullish 12/17/20 Stratasys call volume above normal and directionally bullish

Initiation	LVMH resumed with Overweight, named top idea at JPMorgan » 07:01 03/03/21 03/03 07:01 03/03/21 07:01 LVMUY LVMH $0.00 / + (+0.00%) JPMorgan analyst Chiara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LVMUY LVMH $0.00 / + (+0.00%) 02/22/21 LVMH's Moet Hennessy takes 50% stake in Jay-Z's Armand de Brignac brand 12/31/20 Tiffany holders approve LVMH takeover, deal to close on January 7 10/29/20 LVMH, Tiffany agree to reduced takeover price of $131.50 per share 10/21/20 Coty appoints Isabelle Bonfanti as CCO, Luxury, Jean-Denis Mariani as CDO LVMUY LVMH $0.00 / + (+0.00%) 02/16/21 Morgan Stanley LVMH price target raised to $600 from $555 at Morgan Stanley 02/09/21 RBC Capital LVMH price target raised to EUR 600 from EUR 530 at RBC Capital 02/02/21 Berenberg LVMH initiated with a Buy at Berenberg 02/01/21 Credit Suisse LVMH price target raised to EUR 540 from EUR 520 at Credit Suisse LVMUY LVMH $0.00 / + (+0.00%) 10/15/20 LVMH reports Q3 revenue EUR 11.96B vs. EUR 13.32B last year 10/15/20 LVMH reports Q3 organic revenue down 7% LVMUY LVMH $0.00 / + (+0.00%) 02/10/21 Rihanna's Fenty fashion line put on hold, WWD reports 10/28/20 LVMH, Tiffany near deal to lower takeout price to $131.50 from $135, WSJ says 10/27/20 Tiffany seeks around $132 per share from LVMH, Bloomberg reports 10/27/20 Tiffany close to new deal price of $130-$133 per share from LVMH, CNBC says LVMUY LVMH $0.00 / + (+0.00%) 10/27/20 Fly Intel: Wall Street's top stories for Tuesday 09/09/20 Fly Intel: Wall Street's top stories for Wednesday 09/09/20 Fly Intel: Wall Street's top stories at midday 09/09/20 Fly Intel: Pre-market Movers
Earnings	Wendy's reports Q4 adjusted EPS 17c, consensus 18c » 07:00 03/03/21 03/03 07:00 03/03/21 07:00 WEN Wendy's $21.30 / +0.01 (+0.05%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 11/04/20 Wendy's raises quarterly dividend 40% to 7c per share 10/19/20 Wendy's names Kevin Vasconi as Chief Information Officer WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Recommendations	FuboTV price target lowered to $45 from $50 at BMO Capital » 06:58 03/03/21 03/03 06:58 03/03/21 06:58 FUBO FuboTV $41.96 / +3.24 (+8.37%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options FUBO FuboTV $41.96 / +3.24 (+8.37%) 03/02/21 FuboTV falls 5% to $39.91 after Q4 earnings miss 03/02/21 FuboTV reports Q4 subscription revenue up 91% to $91.4M 02/22/21 Discovery says recognized 126M total gain on FuboTV investment 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel FUBO FuboTV $41.96 / +3.24 (+8.37%) 02/01/21 Wedbush FuboTV price target raised to $50 from $40 at Wedbush 01/21/21 Barrington FuboTV initiated with an Outperform at Barrington 01/19/21 LightShed Partners FuboTV price target lowered to $6.50 from $8 at LightShed Partners 01/12/21 Roth Capital FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital FUBO FuboTV $41.96 / +3.24 (+8.37%) 03/02/21 FuboTV raises FY21 revenue view to $460M-$470M from $415M-$435M 03/02/21 FuboTV sees Q1 revenue $101M-$103M, consensus $99.36M 03/02/21 FuboTV reports Q4 EPS ($2.47), consensus (73c) 01/05/21 FuboTV reports preliminary Q4 revenue $94M-$98M, consensus $87.36M 30 Dec 08 Oct FUBO FuboTV $41.96 / +3.24 (+8.37%) 03/02/21 Fly Intel: After-Hours Movers 02/16/21 Fly Intel: After-Hours Movers 01/21/21 FuboTV jumps as Barrington says buy, Einhorn highlights gains 01/21/21 Snap initiation, PayPal upgrade among today's top calls on Wall Street FUBO FuboTV $41.96 / +3.24 (+8.37%) 01/12/21 Unusually active option classes on open January 12th 01/05/21 Largest borrow rate increases among liquid names 01/04/21 Largest borrow rate increases among liquid names 12/30/20 Unusually active option classes on open December 30th
Hot Stocks	Asensus Surgical receives additional FDA clearance for Senhance Surgical System » 06:57 03/03/21 03/03 06:57 03/03/21 06:57 TRXC TransEnterix $3.90 / +0.17 (+4.56%) Asensus Surgical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TRXC TransEnterix $3.90 / +0.17 (+4.56%) 02/23/21 TransEnterix announces name change to Asensus Surgical 02/18/21 TransEnterix announces new training center in EU 02/18/21 TransEnterix announces new training center in EU 02/11/21 TransEnterix trading resumes TRXC TransEnterix $3.90 / +0.17 (+4.56%) 01/20/21 Ladenburg TransEnterix downgraded to Neutral on valuation at Ladenburg 01/20/21 Ladenburg TransEnterix downgraded to Neutral from Buy at Ladenburg TRXC TransEnterix $3.90 / +0.17 (+4.56%) 01/06/21 TransEnterix sees FY20 revenue $3.0M-$3.2M, consensus $3.11M 01/06/21 TransEnterix sees Q4 revenue $1.1M, consensus $1.04M TRXC TransEnterix $3.90 / +0.17 (+4.56%) 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 03/05/21 Medical Technology TRXC TransEnterix $3.90 / +0.17 (+4.56%) 02/10/21 Largest borrow rate increases among liquid names 02/04/21 Largest borrow rate increases among liquid names 12/18/20 Largest borrow rate increases among liquid names
Downgrade	Black Hills downgraded on additional leverage from Uri at Mizuho » 06:56 03/03/21 03/03 06:56 03/03/21 06:56 BKH Black Hills $59.94 / +0.03 (+0.05%) Mizuho analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BKH Black Hills $59.94 / +0.03 (+0.05%) 03/01/21 Black Hills incurs $600M of additional natural gas costs from weather event 01/26/21 Black Hills gets approval for consolidation and rate increase in Nebraska 12/01/20 Black Hills completes 52.5-megawatt Corriedale wind energy project 11/05/20 Black Hills announces clean energy goals BKH Black Hills $59.94 / +0.03 (+0.05%) 06:29 Today Mizuho Black Hills downgraded to Neutral from Buy at Mizuho 12/15/20 Scotiabank Black Hills upgraded to Outperform on valuation at Scotiabank 12/15/20 Scotiabank Black Hills upgraded to Outperform from Sector Perform at Scotiabank 11/13/20 BofA Black Hills upgraded to Buy from Neutral at BofA BKH Black Hills $59.94 / +0.03 (+0.05%) 02/26/21 Black Hills backs FY21 EPS view $3.80-$4.00, consensus $3.90 02/09/21 Black Hills sees FY22 EPS $3.95 to $4.15 02/09/21 Black Hills raises FY21 EPS view $3.80-$4.00 from $3.75-$3.95, consensus $3.88 02/09/21 Black Hills reports Q4 EPS $1.23, consensus $1.15 04/27/21 Black Hills Corporation

Events

Earnings calls, analyst events, roadshows and more

TSHA
Today at 08:00

Taysha Gene Therapies - TSHA Conference Calls
OPTN
Today at 08:00

Optinose - OPTN Conference Calls
BQ
Today at 08:00

Boqii - BQ Conference Calls
ISEE
Today at 08:00

Iveric bio - ISEE Conference Calls
Today at 08:15

ADP Employment Report: Private Payrolls M/M: February 2021 Government Event
WEN
Today at 08:30

Wendy's - WEN Conference Calls
TAST
Today at 08:30

Carrols Restaurant - TAST Conference Calls
PASG
Today at 08:30

Passage Bio - PASG Conference Calls
CECE
Today at 08:30

CECO Environmental - CECE Conference Calls
SBBP
Today at 08:30

Strongbridge Biopharma - SBBP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

NASDAQ market internals summary

TODAY'S FREE FLY STORIES

Get Full Fly Access